Influence of unreported HIV prophylaxis on the kinetics of post‐blood donation HIV seroconversion
Transfusion2021Vol. 61(12), pp. 3488–3492
Citations Over Time
Anna S. Nishiya, Nanci A. Salles, Cesar de Almeida‐Neto, Steven S. Witkin, Suzete C. Ferreira, Fátima A. H. Nogueira, Tila Facincani, Vanderson Rocha, Alfredo Mendrone
Abstract
The use of anti-viral prophylaxis by blood donors in the acute phase of HIV infection delays seroconversion. A 6-month deferral in blood donation after HIV prophylaxis, as currently recommended in Brazil, would have been sufficient in this case to mitigate the risk of transfusion-transmitted HIV. Ultimately, improvement in donor compliance with selection procedures for blood donation is needed to optimize blood safety.
Related Papers
- → Window period donations during primary cytomegalovirus infection and risk of transfusion‐transmitted infections(2013)33 cited
- → Detection of HIV-1 infections in blood donors during the pre-seroconversion window period in São Paulo, Brazil(2019)5 cited
- → A New Combined HIV p24 Antigen and Anti-HIV-1/2/O Screening Assay(2005)4 cited
- → Genomic detection of human immunodeficiency virus (HIV) by nucleic acid amplification test in a frequent platelet donor during the pre-seroconversion period(2011)4 cited
- → Evaluation of four domestic and three imported fourth-generation HIV diagnostic reagents(2011)